Kawamoto Ryuichi, Kikuchi Asuka, Ninomiya Daisuke, Kumagi Teru, Abe Masanori
Department of Community Medicine, Ehime University Graduate School of Medicine, Toon-City, Ehime, Japan.
Department of Internal Medicine, Seiyo Municipal Nomura Hospital, Seiyo-City, Ehime, Japan.
Alcohol Clin Exp Res (Hoboken). 2025 May;49(5):1097-1105. doi: 10.1111/acer.70037. Epub 2025 Mar 28.
Decreased levels of high-molecular-weight (HMW) adiponectin are associated with metabolic syndrome and insulin resistance. This relationship may be further confounded by alcohol consumption, which plays a role in the development of liver dysfunction. In Japan, few studies have investigated the relationship between HMW adiponectin levels and alcohol consumption with mortality.
The study included 845 male participants (mean age, 61 ± 13 years; range, 20-89 years) and 1065 female participants (mean age, 63 ± 11 years; range, 22-88 years). Of the participants, 809 (42.4%) were classified as nondrinkers, 561 (29.4%) as occasional drinkers, 346 (18.1%) as daily light drinkers, and 194 (10.2%) as daily heavy drinkers. A Cox proportional hazards model was used to calculate hazard ratios (HR) for all-cause mortality, adjusting for various confounders, including HMW adiponectin levels.
Individuals who abstained from alcohol consumption (hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.00-1.52) or engaged in daily heavy drinking (HR, 1.39; 95% CI, 1.04-1.86) exhibited significantly higher overall mortality than occasional drinkers. Additionally, those with the 3rd standard deviation (SD) level of HMW adiponectin (HR, 1.39; 95% CI, 1.07-1.80) and 4th SD level (HR, 1.65; 95% CI, 1.23-2.23) had a similarly increased risk of all-cause mortality compared to those with the lowest levels. After adjusting for confounders, the HR for individuals with the 3rd + 4th SD levels of HMW adiponectin was significantly elevated in nondrinkers (HR, 1.89; 95% CI, 1.09-3.29), occasional drinkers (HR, 1.84; 95% CI, 1.05-3.21), and daily heavy drinkers (HR, 1.90; 95% CI, 1.05-3.44), but not in daily light drinkers. The interaction between alcohol consumption and HMW adiponectin levels was significantly associated with all-cause mortality.
These findings suggest that alcohol consumption and elevated HMW adiponectin levels are interactively associated with all-cause mortality in community-dwelling individuals.
高分子量(HMW)脂联素水平降低与代谢综合征和胰岛素抵抗相关。饮酒可能会进一步混淆这种关系,因为饮酒在肝功能障碍的发展中起作用。在日本,很少有研究调查HMW脂联素水平与饮酒量和死亡率之间的关系。
该研究纳入了845名男性参与者(平均年龄61±13岁;范围20 - 89岁)和1065名女性参与者(平均年龄63±11岁;范围22 - 88岁)。参与者中,809人(42.4%)被归类为不饮酒者,561人(29.4%)为偶尔饮酒者,346人(18.1%)为每日少量饮酒者,194人(10.2%)为每日大量饮酒者。使用Cox比例风险模型计算全因死亡率的风险比(HR),并对包括HMW脂联素水平在内的各种混杂因素进行调整。
戒酒者(风险比[HR],1.23;95%置信区间[CI],1.00 - 1.52)或每日大量饮酒者(HR,1.39;95% CI,1.04 - 1.86)的总体死亡率显著高于偶尔饮酒者。此外,HMW脂联素处于第3标准差(SD)水平(HR,1.39;95% CI,1.07 - 1.80)和第4 SD水平(HR,1.65;95% CI,1.23 - 2.23)的参与者与水平最低者相比,全因死亡风险同样增加。在调整混杂因素后,HMW脂联素处于第3 + 4 SD水平的不饮酒者(HR,1.89;9